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Internalization and Intoxication of Human Macrophages by the Active Subunit of
the Aggregatibacter actinomycetemcomitans Cytolethal Distending Toxin Is
Dependent Upon Cellugyrin (Synaptogyrin-2)
Abstract
The Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is a heterotrimeric AB2
toxin capable of inducing cell cycle arrest and apoptosis in lymphocytes and other cell types. Recently, we
have demonstrated that human macrophages are resistant to Cdt-induced apoptosis but are susceptible
to toxin-induced pro-inflammatory cytokine response involving activation of the NLRP3 inflammasome.
Exposure to Cdt results in binding to the cell surface followed by internalization and translocation of the
active subunit, CdtB, to intracellular compartments. Internalization involves hijacking of retrograde
pathways; treatment of cells with Retro-2 leads to a decrease in CdtB–Golgi association. These events
are dependent upon toxin binding to cholesterol in the context of lipid rich membrane microdomains often
referred to as lipid rafts. We now demonstrate that within 1 h of exposure of macrophages to Cdt, CdtB is
internalized and found primarily within lipid rafts; concurrently, cellugyrin (synaptogyrin-2) also
translocates into lipid rafts. Further analysis by immunoprecipitation indicates that CdtB associates with
complexes containing both cellugyrin and Derlin-2. Moreover, a human macrophage cell line deficient in
cellugyrin expression (THP-1Cg−) challenged with Cdt failed to internalize CdtB and was resistant to the
Cdt-induced pro-inflammatory response. We propose that lipid rafts along with cellugyrin play a critical
role in the internalization and translocation of CdtB to critical intracellular target sites in human
macrophages. These studies provide the first evidence that cellugyrin is expressed in human
macrophages and plays a critical role in Cdt toxicity of these cells. © Copyright © 2020 Boesze-Battaglia,
Dhingra, Walker, Zekavat and Shenker.
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The Aggregatibacter actinomycetemcomitans cytolethal distending toxin (Cdt) is a
heterotrimeric AB2 toxin capable of inducing cell cycle arrest and apoptosis in
lymphocytes and other cell types. Recently, we have demonstrated that human
macrophages are resistant to Cdt-induced apoptosis but are susceptible to toxininduced pro-inflammatory cytokine response involving activation of the NLRP3
inflammasome. Exposure to Cdt results in binding to the cell surface followed
by internalization and translocation of the active subunit, CdtB, to intracellular
compartments. Internalization involves hijacking of retrograde pathways; treatment of
cells with Retro-2 leads to a decrease in CdtB–Golgi association. These events are
dependent upon toxin binding to cholesterol in the context of lipid rich membrane
microdomains often referred to as lipid rafts. We now demonstrate that within 1 h
of exposure of macrophages to Cdt, CdtB is internalized and found primarily within
lipid rafts; concurrently, cellugyrin (synaptogyrin-2) also translocates into lipid rafts.
Further analysis by immunoprecipitation indicates that CdtB associates with complexes
containing both cellugyrin and Derlin-2. Moreover, a human macrophage cell line deficient
in cellugyrin expression (THP-1Cg− ) challenged with Cdt failed to internalize CdtB and
was resistant to the Cdt-induced pro-inflammatory response. We propose that lipid rafts
along with cellugyrin play a critical role in the internalization and translocation of CdtB to
critical intracellular target sites in human macrophages. These studies provide the first
evidence that cellugyrin is expressed in human macrophages and plays a critical role in
Cdt toxicity of these cells.
Keywords: cytolethal distending toxin, Aggregatibacter actinomycetemcomitans, macrophages, bacterial toxins,
cellugyrin, lipid rafts
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INTRODUCTION

that in lymphocytes, cellugyrin plays a key role in CdtB
internalization. Specifically, we have demonstrated that soon
after exposure to Cdt, lymphocytes exhibit translocation of
the host cell protein cellugyrin (synaptogyrin-2) to the same
cholesterol rich microdomains in which CdtB is observed
to initially accumulate. In addition to co-localization, it was
determined through immunoprecipitation studies that CdtB
and cellugyrin are part of the same complex. Moreover,
reduced expression of cellugyrin protected cells from Cdtmediated toxicity: cell cycle arrest and apoptosis (29). In
this study, we extend our initial observations to determine if
cellugyrin is also critical to CdtB translocation and toxicity in
human macrophages.

Cytolethal distending toxins (Cdt) are a family of protein
exotoxins produced by over 30 γ- and ε-Proteobacteria; these
human and/or animal pathogens share the common property
of an ability to colonize mucocutaneous tissue (1, 2). Moreover,
recent studies suggest that Cdts contribute to the persistence,
invasiveness and severity of disease associated with Cdtproducing organisms (3–8). Key to the toxicity of these exotoxins
is the requirement to facilitate internalization of the active Cdt
subunit to intracellular compartments. In this regard, most Cdts,
including the Aggregatibacter actinomycetemcomitans Cdt are
heterotrimeric holotoxins that function as AB2 toxins. In this
toxin model, the CdtA and CdtC subunits serve as the binding
complex (B) and CdtB as the internalized active subunit (A)
[reviewed in (1, 9)]. In order to deliver CdtB to intracellular
compartments the holotoxin must first bind to target cell
surfaces. Several investigators have demonstrated that the CdtC
subunit of several Cdts, including the A. actinomycetemcomitans
Cdt, bind to membrane cholesterol (10–17). Cholesterol binding
in the context of membrane microdomains was demonstrated
utilizing both model membranes and live cells including both
lymphocytes and macrophages (10–12). Binding was shown to
be dependent upon an amino acid sequence, the cholesterol
recognition amino acid consensus sequence (CRAC) encoded
within the CdtC subunit. A similar cholesterol recognition unit
is present within CdtB and is required for internalization of
this subunit (12). Currently, the exact role for CdtA in toxin
binding is unclear. CdtA shares structural homology with lectinlike proteins; studies have suggested that fucose moieties as well
as glycosphingolipids might be involved in the interaction of this
subunit with the cell surface (13, 18–20).
Once CdtB is internalized, it must reach intracellular
compartment(s) to intoxicate cells. To date, the identification
of the specific intracellular compartment(s) is unclear and is
likely dependent on CdtB’s mode of action. In this regard
it has been demonstrated that CdtB exhibits two enzymatic
activities: DNase and lipid phosphatase (1, 21–24). In the case
of the former activity, it is believed that the active subunit must
translocate to the nucleus where it induces double-strand DNA
breaks. In contrast, the lipid phosphatase activity, specifically
phosphatidylinositol (PI) 3,4,5-triphosphate (PIP3) phosphatase
activity requires that CdtB transits to intracellular pools of PIP3
where it is capable of depleting cells of this lipid signaling
molecule and inducing PI-3K signaling blockade (24). PIP3 pools
exist in proximity to the internal leaflet of the plasma membrane
as well as in association with other intracellular membranes
including transport vesicles (25, 26). Thus, internalization of
CdtB and translocation to requisite intracellular compartments
is likely dependent upon its mode of action which in turn is
likely determined by the bacterial source of Cdt as well as the
specific target cell. Regardless of the intracellular site, it has been
demonstrated that CdtB traffics by retrograde transport to the
Golgi and the endoplasmic reticulum (ER) (27, 28).
In recent studies, we (29) and Carette et al. (30, 31) have
identified a link between Cdt toxicity and a host cell protein
cellugyrin (synaptogyrin-2). Furthermore, we have demonstrated
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MATERIALS AND METHODS
Reagents and Antibodies
The following antibodies were obtained from Cell Signaling
Technology (Danvers, MA): rabbit anti-EEA1 mAB, rabbit antiRCAS1 mAb, rabbit anti-AIF mAb and rabbit anti-LAMP1
mAb. Mouse anti-CdtB mAb conjugated to AlexaFluor 488 was
generated in our laboratory (see below) and mouse anti-rabbit
IgG AlexaFluor 594 was purchased from Invitrogen (Carlsbad,
CA). Western blot and immunoprecipitation studies utilized
the following antibodies: anti-CdtB mAb, anti-CdtC mAb, and
anti-cellugyrin antibody which were generated in our laboratory
as previously described (10, 29); additional antibodies include:
rabbit anti-derlin-2 (Sigma Aldrich, St. Louis, MO), goat antimouse Ig-HRP conjugate, goat anti-rabbit Ig-HRP conjugate
(Southern Biotech; Birmingham, AL), mouse anti-transferrin
receptor (TfR) mAb (BD Biosciences; San Jose, CA), and rabbit
anti-caveolin anti-sera (Sigma Aldrich). Additional reagents
include: Retro-2 (Sigma Aldrich) and cholera toxin B (CTB)
conjugated to AlexaFluor 594 (Invitrogen).
Construction and expression of the plasmid containing the cdt
genes for the Cdt holotoxin (pUCAacdtABChis) have previously
been reported (11). The histidine-tagged holotoxin was isolated
by nickel affinity chromatography. Experiments conducted in
this report employed Cdt at the following concentrations: 8
ng/m (0.157 mM), 40 ng/ml (0.784 mM), 200 ng/ml (3.9 mM),
and 1 µg/ml (19.5 mM).

Cell Culture and Lentiviral Transfection
The human acute monocytic leukemia cell line, THP-1, obtained
from ATCC were maintained in RPMI 1640 containing
10% FBS, 1 mM sodium pyruvate, 20 µM 2-mercaptoethanol
and 2% penicillin-streptomycin at 37◦ C with 5% CO2 in a
humidified incubator. THP-1 cells stably expressing shRNA
against cellugyrin (THP-1Cg− ) and control cells (THP-1shctl )
were prepared with commercially available Lentiviral particles
(Santa Cruz Biotech; Dallas, TX). The cells were prepared by
transducing THP-1 cells with Lentiviral particles, along with nontarget controls, as previously described (32, 33). Expression levels
were assessed by Western blot. THP-1 cells were differentiated
into macrophages by incubating cells in the presence of 50 ng/ml
PMA for 48 h at which time the cells were washed and incubated
an additional 24 h in medium prior to use.
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Isolation of Triton X-100 Resistant
Membrane Rafts

washed again and processed for immunostaining with anticellugyrin antibody. Briefly, the cells were blocked in blocking
solution containing 5% BSA and 0.2% Triton X-100 in PBS
(PBST) at 37◦ C for 1 h, incubated with anti-cellugyrin antibody
conjugated to AlexaFluor488 diluted in blocking solution, and
Hoechst 33258 at 4◦ C overnight, washed three times with PBST.
Images were captured on a Nikon A1R laser scanning confocal
microscope with a 100× (oil) objective at 18◦ C, and the data
were analyzed using Nikon Elements AR 4.30.01 software. To
estimate cellugyrin associated with raft, intensity thresholds were
applied to the two channels (green and red) for the control and
Cdt treated cells in each experiment; binary images were used
to determine intersection area between cellugyrin (green) and
raft (red) stained structures in each field. Intersection area was
then normalized to total cellugyrin positive area for comparisons
across experiments. Two-tailed, one sample T-test was used to
test if mean cellugyrin associated with lipid rafts (normalized to
total cellugyrin) in Cdt treated cells relative to control cells was
different from 1.
Trafficking studies were performed as follows. Differentiated
THP-1WT or THP-1Cg− cells grown on glass bottom dishes
were incubated with 2 µg/ml Cdt holotoxin at 4◦ C for 30 min
to facilitate binding, followed by 37◦ C for 45 min to stimulate
uptake. Cells were subsequently washed in PBS and fixed in 4%
PFA for 15 min at RT. For retrograde inhibition experiments,
differentiated THP-1WT cells grown on glass bottom dishes were
treated with Retro-2 (100 µM) or in medium (control) at 37◦ C
for 30 min, followed by addition of 1 µg/ml Cdt holotoxin and
incubation at 4◦ C for 30 min and then at 37◦ C for 45 min in
the continued presence of Retro-2 (100 µM). Cells were washed
in PBS and fixed in 4% PFA for 15 min at RT. The cells were
immunostained for the CdtB subunit and intracellular markers
as described below for immunostaining.
Immunostaining was performed on PFA fixed cells that were
permeabilized and blocked in 5% BSA and 0.2% Triton X-100 in
PBS (PBST) at 37◦ C for 1 h. Cells were then incubated with the
primary antibody diluted in blocking solution at 4◦ C overnight,
washed three times with PBST, incubated with appropriate
secondary antibodies conjugated to AlexaFluor 594 and Hoechst
33258 at 37◦ C for 1 h and washed three times. Immunostaining
was performed using anti-CdtB mAb conjugated to AlexaFluor
488 antibody along with different intracellular marker antibodies:
EEA1, RCAS1; AIF; LAMP1. Images were captured on a Nikon
A1R laser scanning confocal microscope with a 100× (oil)
objective at 18◦ C, and the data were analyzed using Nikon
Elements AR 4.30.01 software. To estimate the levels of CdtB
subunit associated with golgi, golgi stained structures (red) were
identified by drawing regions of interest (ROI) and sum intensity
of CdtB stained structures (green) within each ROI was estimated
and plotted as a percentage of total CdtB in the field for both
control and Retro-2 treated samples.

Triton X-100 resistant membrane rafts were prepared from THP1WT cells that were incubated in the presence of medium or
Cdt holotoxin for 2 h. Following the incubation period, cells
were harvested, washed and lysed in the presence of Triton
X-100 as previously described (10). The lysates were further
fractionated on a density gradient using a commercially available
kit (Sigma) as previously described (10). Lysates were layered
onto the gradients and centrifuged at 200,000 × G for 4 h at
4◦ C. Two prominent bands were recovered, designated DRM1
and DRM2; these were washed and resuspended in 0.2 ml HEPES
buffer. Additionally, two soluble fractions, designated S1 and S2
were obtained from the bottom two 0.5 ml fractions.

Immunoprecipitation and Western Blot
Analysis
Cells were treated as described above and solubilized in
20 mM Tris-HCl buffer (pH7.5) containing 150 mM NaCl,
1 mM EDTA, 1% NP-40, 1% sodium deoxycholate and protease
inhibitor cocktail (ThermoFisher Scientific; Waltham, MA).
Samples (30 µg) were separated on 12% SDS-PAGE and then
transferred to PVDF membranes. The membrane was blocked
with BLOTTO and then incubated with one of the primary
antibodies (as indicated) for 18 h at 4◦ C as previously described
(29). Membranes were washed and incubated with goat antimouse immunoglobulin conjugated to horseradish peroxidase
(Southern Biotech Technology; Birmingham, AL). The Western
blots were developed using chemiluminescence and analyzed
by digital densitometry (Li Cor Biosciences; Lincoln, NE) as
previously described (34).
Immunoprecipitation studies were performed with antibody
to cellugyrin or CdtB which were immobilized by crosslinking
to protein A/G using the Pierce Crosslink IP kit (ThermoFisher
Scientific) as previously described (29). THP-1 cells were
incubated with medium or Cdt (2 µg/ml) for 2 h at 37◦ C and then
lysed and centrifuged at 5,000 × g for 5 min. Supernatants were
loaded onto columns containing the protein A/G with crosslinked antibody and incubated overnight at 4◦ C. The columns
were washed and the immunoprecipitated protein eluted and
analyzed by Western blot as described above. Western blots were
probed using anti-cellugyrin antibody, anti-Cdt subunit mAb or
anti-derlin-2 followed by reporter antibody conjugated to HRP.

Confocal Microscopy
Analysis of cellugyrin association with membrane microdomains
was performed as follows. Differentiated THP-1 cells grown
on glass bottom dishes were incubated with or without Cdt
holotoxin (2 µg/ml) for 1 h at 37◦ C, and washed twice with
medium. Membrane lipid raft staining was performed by
incubating the cells with 1 µg/ml inactive cholera toxin B (CTB)
conjugated to AlexaFluor 594 for 30 min at 4◦ C. The cells were
washed in medium (without serum), incubated with mouse
anti-CTB antibody at 4◦ C for 30 min followed by 37◦ C for
30 min, washed and fixed in cold methanol (−20◦ C) for 15 min,

Frontiers in Immunology | www.frontiersin.org

Flow Cytometric Analysis of Cdt Binding
and CdtB Internalization
Cdt binding and CdtB internalization was detected by incubating
THP-1WT and THP-1Cg− macrophages for 30 min (surface
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staining; 5◦ C) or 1 h (intracellular staining; 37◦ C) in the presence
of medium or 2 µg/ml of Cdt. Surface Cdt was assessed by
staining cells with anti-CdtC (or anti-CdtB) conjugated to
AlexaFluor 488 followed by flow cytometric analysis as previously
described (11). Briefly, cells were washed, exposed to normal
mouse IgG (Zymed Labs; San Franscisco, CA) and then stained
(30 min) for the Cdt subunit with anti-CdtC (or anti-CdtB)
subunit mAb conjugated to AlexaFuor 488 (Molecular Probes;
Eugene, OR). Following fixation with 2% paraformaldehyde the
cells were analyzed by flow cytometry. Intracellular CdtB was
detected after exposure of cells to toxin (or medium) and fixation
with 2% formaldehyde for 30 min followed by permeabilization
with 0.1% Triton X-100 in 0.1% sodium citrate. Cells were and
stained with anti-CdtB mAb conjugated to Alexa Fluor 488. Note
that this protocol does not detect surface associated CdtB.

as detergent soluble fractions, S1 and S2 with refractive indexes
of 1.392 and 1.402, respectively. We used these same parameters
in our analysis of detergent resistant CdtB containing fractions
isolated from lymphocytes (10).
Aliquots of each of these four fractions obtained from both
control cells and Cdt-treated cells and were analyzed by SDSPAGE and Western blot (Figure 1B). Two Cdt subunits, CdtC,
the cholesterol binding subunit, and CdtB, the active subunit
were found primarily in DRM1. Cellugyrin distribution was
also assessed; in control cells (no toxin), cellugyrin was found
primarily in the non-lipid raft fractions S1 and S2. However,
treatment with Cdt resulted in the translocation of cellugyrin to
DRM1. For control purposes, the distribution of caveolin and
TfR was also assessed; caveolin, a lipid raft protein, was found
in DRM1 and DRM2 in untreated cells, but only in DRM1
in Cdt treated cells. In contrast, TfR, a non-lipid raft protein,
was observed in the S1 and S2 fractions in untreated and Cdt
treated cells. The translocation of cellugyrin into membrane
microdomains was confirmed using fluorescence microscopy.
As shown in Figures 1C,D, lipid raft associated cellugyrin
fluorescence increased in Cdt treated cells; this translates to
1.6-fold increase in cellugyrin localization to rafts (Figure 1E).
It has been established in several cell types that once
internalized, CdtB traffics in a retrograde manner to the
Golgi apparatus and on to the ER (9, 27, 28). We first
demonstrate that CdtB transport to Golgi also occurs in
THP-1WT macrophages (Figure 2). Macrophages treated
with Cdt exhibit CdtB fluorescence that is co-localized
with early endosomes (EEA1; also see Figure S1) and the
Golgi (RCAS1). We did not observe any CdtB fluorescence
co-localization with Lamp1, a late endosome marker or
mitochondria (AIF); the latter was employed as a control
(Figure 2).
In the next series of experiments, we assessed the requirement
for CdtB localization using the inhibitor, Retro-2, a nontoxic inhibitor of endosome-to-Golgi retrograde transport. This
inhibitor has been employed in other studies to protect cells
from toxins, such as ricin, cholera, and Shiga (35, 36); it also
inhibits infection by viruses, such as polyoma, papilloma, AAV,
and filoviruses by inhibiting retrograde transport (37–40). Retro2 has been reported to not alter compartment morphology,
endogenous retrograde cargos, or other trafficking steps, such
as endocytosis, recycling and degradation (40). CdtB localized
to Golgi in the absence of the retrograde transport inhibitor
Retro 2 (Figures 3A,B and Figure S2). The linear intensity
profile depicts considerable correlation between RCAS1 and
CdtB in the absence of Retro-2 (Figure 3A, boxed regions lower
panel). Retro-2 treatment resulted in a significant reduction in
CdtB associated with Golgi from 15.1 ± 0.01 to 11.6 ± 0.01%
(Figures 3A,C). There was no discernible change in Lamp1
and CdtB localization after Retro-2 treatment (Figure 3B). The
linear intensity profiles (Figure 3B) suggest that the inhibition
of retrograde transport of Cdt does not result in diversion
of CdtB to the late endosomal/lysosomal route, as there was
little correlation between CdtB and LAMP1 signal. Moreover,
macrophages pre-treated with Retro-2 (0–250 µM) exhibited a
significant reduction in TNFα release (Figure 3D); untreated
control cells did not produce detectable TNFα; in the presence of

Measurement of Cytokine Release by
ELISA
Cytokine production was measured in THP-1 derived
macrophages incubated for 5 h in the presence or absence
of varying amounts of Cdt (0–200 ng/ml). Culture supernatants
were collected and analyzed by ELISA for IL-1β (Quantikine Elisa
Kit; R and D Systems) or TNFα (Peprotech) using commercially
available kits according to the manufacturer’s instructions. In
each instance, the amount of cytokine present in the supernatant
was determined using a standard curve.

RESULTS
It is well-established that in order to intoxicate cells, the
active Cdt subunit, CdtB, must be internalized and then
transported to intracellular compartments. Although there is
some disagreement as to which intracellular site(s) CdtB
must reach to be effective, it is generally accepted that the
subunit first traffics in a retrograde manner through the Golgi
into the endoplasmic reticulum (ER). In previous studies we
identified three key events that must occur prior to intoxication.
First, Cdt association with both lymphocytes and macrophages
involves binding to cholesterol in the context of cholesterol
rich membrane microdomains (10–12). Second, internalized
CdtB in lymphocytes was observed to initially accumulate in
these cholesterol rich microdomains (lipid rafts) (10). Third,
transport from the membrane to intracellular compartments in
lymphocytes was observed to be dependent upon association
with a complex containing cellugyrin (synaptogyrin 2), a nonneuronal paralog of the synaptic vesicle protein, synapogyrin
1 (29). Therefore, to advance our understanding of the early
events leading to Cdt-induction of pro-inflammatory responses
in human macrophages, we first determined if CdtB is also
found initially associated with lipid rafts. THP-1WT -derived
macrophages were treated with Cdt (1 µg/ml) for 60 min; lipid
rafts were isolated as detergent resistant membrane (DRM)
fractions. As shown in Figure 1A, two prominent DRM bands
were identified, DRM1 (D1) and DRM2 (D2); these bands were
eluted from the sucrose gradient in fractions corresponding to
refractive indexes of 1.359 and 1.374, respectively. Additionally
we collected the bottom two 0.5 ml fractions and designated them
Frontiers in Immunology | www.frontiersin.org
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FIGURE 1 | Cdt-induces translocation of cellugyrin to cholesterol rich microdomains. THP-1WT -derived macrophage were treated with medium or Cdt (1 µg/ml) for
1 h. Cells were harvested, washed, and cholesterol rich microdomains isolated as detergent resistant membranes (DRM) as described in Materials and Methods. (A)
Shows the two DRM zones, DRM1 (D1) and DRM2 (D2), on the sucrose gradient; additionally two soluble fractions were collected, designated S1 and S2, which
contain the bottom 0.5 ml (each) of the gradient. (B) Each fraction was analyzed by Western blot for the presence of CdtB, CdtC, cellugyrin, caveolin (lipid raft marker)
and the transferrin receptor (TfR) (non-raft membrane marker). S refers to unfractionated start material. (C,D) Representative confocal images of differentiated
untreated THP-1WT cells (Ctl; C) or treated with 1 µg/ml Cdt (+Cdt; D) and stained for rafts (red) and cellugyrin (green). (E) Shows the fold change in cellugyrin
(Continued)
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FIGURE 1 | associated with lipid rafts in Cdt treated cells relative to untreated cells (normalized to total cellugyrin). Dashed horizontal line represents unity. Results are
from three experiments (4–7 fields per experiment); p < 0.05 (two-tailed one sample t-test). The degree of overlap between cellugyrin and lipid raft staining was
estimated by Pearson’s correlation coefficient of 0.72 ± 0.04 and 0.73 ± 0.03 (mean ± SEM), n = 10 ROI for control and Cdt-treated cells, respectively.

FIGURE 2 | CdtB localizes to early endosomes and Golgi. Confocal micrographs of differentiated THP-1WT cells treated with Cdt holotoxin and immunostained for the
indicated organelle markers (red), CdtB (green), and merge (yellow). EEA1, early endosome; RCAS1, Golgi marker; Lamp1, lysosome marker; AIF, mitochondrial
marker.

Cdt (200 ng/ml) alone, cells released 4,165 ± 135 pg/ml TNFα. In
contrast cells pre-treated with Retro-2 and Cdt exhibited 3,328 ±
488 pg/ml (50 µM Retro-2), 3,028 ± 544 pg/ml (100 µM Retro-2)
and 2,000 ± 266 pg/ml (250 µM Retro-2) TNFα.
As noted above, we have previously demonstrated that
CdtB and cellugyrin not only co-localize within lipid rafts,
but we have also observed, using both surface plasmon
resonance (SPR) and immunoprecipitation, that the two proteins
are found associated with one another (29). Therefore, we
next employed immunoprecipitation to determine if toxin
treatment of macrophages also leads to an association between
cellugyrin and CdtB. THP-1WT macrophages were treated with
medium alone (control) or with Cdt (2 µg/ml) for 2 h. Cell
extracts were prepared and Western blot analyses performed
on immunoprecipitates obtained using immobilized antiCdtB or anti-cellugyrin antibodies. As shown in Figure 4,

Frontiers in Immunology | www.frontiersin.org

immunoprecipitation with anti-CdtB pulled down both CdtB
and cellugyrin. Immunoprecipitation with anti-cellugyrin
antibody pulled down cellugyrin in control cells as well as
both cellugyrin and CdtB in the toxin treated cells. In addition
to cellugyrin, Eshraghi et al. (27) have recently demonstrated
that components of the ER associated degradation (ERAD)
machinery are critical to the intracellular transport of CdtB.
Therefore, we also assessed the immunoprecipitate for Derlin
2, an ERAD component. As shown in Figure 4, anti-CdtB
pulled down Derlin-2 from extracts derived from toxin treated
cells. The anti-cellugyrin antibody pulled down Derlin-2 from
untreated cells; Derlin-2 was also found in immunoprecipitates
of extracts from toxin treated cells, but to a lesser degree than
observed with control cells.
To advance our understanding of the biological significance
of Cdt and cellugyrin association, perhaps within in the
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FIGURE 3 | Retro-2 blocks retrograde transport of CdtB to Golgi. Confocal images showing maximum intensity projections (from 6 µn Z stack) of differentiated
THP-1WT cells pre-treated for 1 h with medium alone (left) or with Retro-2 (100 µM, right); both samples then received Cdt (1 µg/ml). After 1 h, cells were stained for
CdtB and RCAS1 or Lamp1. Nuclei stained with Hoechst are pseudo-colored in cyan. (A) Maximum intensity projections for CdtB (green) and RCAS1 (red). Bottom
graphs represent intensity profiles for CdtB (green), RCAS1 (red), and Hoechst nuclear stain (blue) across dotted lines depicted. Boxed regions correspond to RCAS1
and CdtB positive structures (marked by white arrows in the top panel). (B) Maximum intensity projections for CdtB (green) and Lamp1 (red). Bottom graphs represent
intensity profiles for CdtB (green), Lamp1 (red), and nuclear stain (blue) across dotted lines depicted. AU, arbitrary units. All images are representative of four
independent experiments (3–4 fields per experiment). (C) Shows the results of the analysis for the percent of CdtB associated with Golgi with and without Retro-2.
Data are plotted as mean ± SEM. (D) THP-1WT macrophages were treated with Retro-2 and Cdt as described above; 5 h later supernatants were analyzed by ELISA
for TNFα. Results are the average (pg/ml) TNFα ±SEM of three experiments; *indicates statistical significance (p < 0.05).

cellugyrin expression (THP-1Cg− ) was prepared using stable
transfection with Lentiviral particles containing cellugyrin
specific shRNA (Figure 5B inset). Macrophages derived from
the THP-1Cg− cells were first assessed for their susceptibility
to induction of a pro-inflammatory cytokine response by
Cdt. THP-1WT and THP-1Cg− cells were treated with 0–
200 ng/ml Cdt; supernatants were analyzed by ELISA for
the presence of IL-1β and TNFα (Figures 5A,B). Cdt-treated
THP-1WT cells exhibited dose-dependent increases in IL-1β:
105 pg/ml (0 Cdt), 250 pg/ml (8 ng/ml Cdt), 345 pg/ml
(40 ng/ml Cdt), and 438 pg/ml (200 ng/ml). Control transfected
cells (THP-1shctl ) exhibited similar levels of IL-1β release.
In contrast THP-1Cg− macrophages produced significantly
less IL-1β: 61 pg/ml (0 Cdt), 80 pg/ml (8 ng/ml Cdt), 130
pg/ml (40 ng/ml Cdt), and 149 pg/ml (200 ng/ml Cdt). Similar
results were observed for the release of TNFα; THP-1WT
cells exhibited a dose dependent increase in this cytokine: 36
pg/ml (0 Cdt), 514 pg/ml (8 ng/ml Cdt), 950 pg/ml (40 ng/ml),
and 1,313 pg/ml (200 ng/ml). THP-1shctl cells exhibited a
comparable TNFα response. In contrast THP-1Cg− exhibited
a significant reduction in TNFα release (relative to THP-1WT

FIGURE 4 | Immunoprecipitation of cellugyrin, Derlin-2, and CdtB. THP-1WT
cells were treated with medium or Cdt (2 µg/ml) for 2 h and then washed and
homogenized as described in Materials and Methods. Supernatants were
immunoprecipitated with either immobilized anti-CdtB or anti-cellugyrin. The
bound protein was eluted and analyzed by Western blot for the presence of
CdtB, celluygrin, and Derlin-2. Results are representative of three experiments.

context of a macromolecular complex, we next determined
if cellugyrin was critical for Cdt association with cells,
CdtB internalization and/or toxicity. A cell line deficient in
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FIGURE 5 | Comparison of THP-1WT - and THP-1Cg− -derived macrophages on susceptibility to Cdt-induced pro-inflammatory response, Cdt holotoxin binding and
CdtB internalization. (A,B) Macrophages derived from THP-1WT (solid bars) THP-1schctl (hatched bars) and THP-1Cg− (cross-hatched bars) cells were treated with
varying amounts of Cdt for 5 h; supernatants were harvested and analyzed by ELISA for IL-1β (A) and TNFα (B). Data are plotted as the mean ± SEM (pg/ml) and
represent the results from three experiments. Inset in (B) shows Western blot analysis of cellugyrin in undifferentiated (U) and differentiated (D) cells derived from
(Continued)
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FIGURE 5 | THP-1WT - and THP-1Cg− cells. (C) Shows the results of flow cytometric analysis of Cdt binding to THP-1WT - and THP-1Cg− -derived macrophages. Cells
were incubated for 60 min at 5◦ C with Cdt (1 µg/ml), washed and stained for the presence of cell surface associated Cdt using anti-CdtC mAb conjugated to
AlexaFlour488. The mean channel fluorescence [mcf; (mean±SEM)] for three experiments is shown. (D) Shows the flow cytometric analysis of CdtB internalization.
THP-1WT - and THP-1Cg− -derived macrophages were incubated with Cdt as above except at 37◦ C. Cells were washed, fixed, permeabilized and stained with
anti-CdtB mAb conjugated to AlexaFluor488. The mcf (mean ± SEM) for three experiments is shown. (E) Shows the confocal microscopic analysis of CdtB
localization to early endosomes or Golgi in THP-1WT - and THP-1Cg− cells. Confocal micrographs of Cdt-treated cells immunostained for CdtB (green) and RCAS1
(red, top) or EEA1 (red, bottom). CdtB signal (green) was enhanced in the panel on the right. Nuclei stained with Hoechst are pseudo-colored in cyan.

and THP-1shctl derived macrophages): 34 pg/ml (0 Cdt), 159
pg/ml (8 ng/ml Cdt), 267 pg/ml (40 ng/ml), and 145 pg/ml
(200 ng/ml).
In the last series of experiments we determined if THP1Cg− -derived macrophages were capable of binding Cdt, able
to internalize CdtB and/or whether the active subunit trafficked
to the endosomes and Golgi. Holotoxin binding to the cell
surface was carried out at 5◦ C and monitored by flow
cytometry using anti-CdtC mAb conjugated to AlexaFluor 488
(Figure 5C). THPWT cells were capable of binding toxin as
they exhibited mean channel fluorescence (mcf) of 9.7 ± 2.1;
control cells exhibited a mcf of 4.3 ± 0.3. Likewise, THP1Cg− cells retained the capacity to bind Cdt; they exhibited a
statistically significant increase in binding over control THP1Cg− cells with mcfs of 14.7 ± 4.4 (+Cdt) vs. 5.1 ± 0.72 (–
Cdt). In addition to utilizing CdtC association with the cell
surface as a surrogate of holotoxin binding, we carried out
similar analysis for surface association of CdtB (Figure S3).
Similar to the results with CdtC, we observed CdtB fluorescence
in both THP-1WT and THP-1Cg− cells. It is interesting to
note that both assessments indicate greater amounts of toxin
(i.e., subunit fluorescence) in macrophages derived from THP1Cg− cells.
Cells were also assessed for their ability to internalize
CdtB (Figure 5D). Following exposure to Cdt at 37◦ C, cells
were evaluated by measuring immunofluorescence with antiCdtB mAb conjugated to AF488 following fixation and
permeabilization. THP-1WT cells exhibited significant CdtB
internalization; mcf of Cdt treated cells was 16.7 ± 17 vs.
5.2 ± 0.2 in control cells. In contrast, THP-1Cg− cells did
not exhibit significant internalization of CdtB as the mcf
was 8.7 ± 1.2 in the presence of Cdt and 5.9 ± 0.3 in
untreated cells. It should be noted that in previous studies we
have demonstrated that the immunofluorescence due to CdtB
internalization observed in THP-1WT cells was dependent on
both permeabilization and temperature; cells not permeabilized
or those incubated at 5◦ C failed to exhibit fluorescence when
stained with anti-CdtB mAb. The failure of THP-1Cg− cells to
internalize CdtB was also confirmed by fluorescence microscopy
(Figure 5E).

Figure 6). Once internalized, CdtB was found to be part of
an intracellular complex that includes cellugyrin and Derlin2. The expression of cellugyrin, its translocation to lipid
rafts and association within a complex containing CdtB and
Derlin-2 in human macrophages are novel observations.
It should be noted that this relationship was not entirely
surprising based upon both our previous studies with Cdt
and cellugyrin in lymphocytes (29) and those of Eshraghi
et al. (27) who identified a critical role for Derlin-2 as
a requisite component of retrograde transport of CdtB.
Moreover, macrophages derived from cellugyrin deficient
cells (THP-1Cg− ) retain the capacity to bind Cdt holotoxin,
but do not internalize CdtB and are not susceptible to
its toxicity which in macrophages is characterized by a
pro-inflammatory cytokine response. These findings are
consistent with our previous observation that celluygrin is
also essential for CdtB internalization and toxicity in human
lymphocytes (29).
The ability of Cdt to bind to regions in target cell membranes
rich in cholesterol, such as lipid rafts is not surprising. We
have previously demonstrated that both CdtC, a component of
the toxin binding unit, and CdtB contain CRAC sites which
are critical for cholesterol binding and internalization (11);
mutation of these sites blocks these events. The significance of
Cdt association with cholesterol rich membrane microdomains
likely relates to their reported role in serving as regions to
concentrate toxins and, more importantly, provide access to
endocytic processes (41–43). Indeed, CdtB internalization has
been linked to endocytic mechanisms dependent upon dynamin
and involving clathrin coated pits (44, 45).
It is now well-established that once internalized, CdtB traffics
by retrograde transport from early endosomes to the Golgi and
then on to the ER (27, 28, 44–49). Both the transport mechanism
and specific location(s) beyond that of the ER is not clear and is
likely linked to CdtB’s mode of action which is discussed below.
Recently, Eshraghi et al. (27) have reported that intracellular
trafficking of CdtB beyond the Golgi involves the ERAD pathway.
In contrast, other studies suggest that this pathway is not involved
in CdtB transport and toxicity. Regardless, we confirm that
CdtB must translocate to the Golgi as Retro-2, an inhibitor
of endosome-Golgi transport, disrupts CdtB translocation in
macrophages; importantly, this blockade also leads to inhibition
of cell susceptibility to toxicity.
Our study also demonstrates that cellugyrin must be present
for CdtB to be internalized in macrophages. Cellugyrin is
a member of a family of proteins known as synaptogyrins
which contain four transmembrane regions with a tyrosinephosphorylated tail (50). Three synaptogyrin isoforms exist.

DISCUSSION
In this study we demonstrate that the binding of Cdt to
human macrophages leads to the association of the active
subunit, CdtB, with cholesterol rich membrane microdomains.
Exposure to Cdt also leads to the translocation of the
host cell protein, cellugyrin, to lipid rafts (summarized in
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FIGURE 6 | Schematic model showing proposed CdtB-cellugyrin interaction. Cdt holotoxin binds to cells via cholesterol in the context of membrane lipid rafts. CdtB
internalization is further dependent upon its ability to interact with cholesterol. As a result of exposure to Cdt, cellugyrin (shown in red) containing SLMVs translocate
from cytosol to membrane lipid rafts. We propose that this translocation leads to association of CdtB with the cellugyrin-containing SLMVs. This interaction may
involve direct binding to cellugyrin either on extra- or intra-vesicular loops or indirect association via an unidentified binding partner (shown in black). We further
propose that CdtB is transported via SLMVs to intracellular target sites; for example sites containing PIP3 pools where the enzymatically active CdtB subunit is
released from SLMVs and is then able to degrade the signaling lipid resulting in PI-3K blockade and toxicity.

In addition to a potential role in transport vesicles, there is
now increasing evidence that cellugyrin, and in turn, cellugyrincontaining SLMVs is a host target that is hijacked by pathogens
for the purposes of intracellular trafficking and retrograde
transport. Our studies suggest that cellugyrin plays a critical
role in the internalization/transport of CdtB from the cholesterol
rich membrane microdomains to intracellular compartments. It
has also been shown that viruses exploit these same SLMVs.
Sun et al. (56) first reported on the role of cellugyrin in
the infection of mammalian cells by Bunyavirus which is
responsible for severe fever with thrombocytopenia syndrome
virus (SFTSV). Cellugyrin was shown to interact with nonstructural viral proteins and further, these interactions led to
the transport of these proteins into inclusion bodies that were
“reconstructed from lipid droplets” during viral infection. The
importance of this translocation was demonstrated by silencing
cellugyrin expression which resulted in reduced inclusion body
formation and viral titers. More recently, Walker et al. (57)
reported on Porcine circovirus 2 (PCV2) which is responsible

Synaptogyrin 1 and 3 are neuronal and are the most abundant
protein in synaptic vesicles; these are critical to vesicle
biogenesis, exocytosis and endocytotic recycling as well as
neurotransmission (51). Synaptogyrin-2 (cellugyrin) is expressed
in all tissue, except brain; it is considered to be a component
of synaptic-like microvesicles (SLMVs) (50, 52–54). Cellugyrin,
like synaptogyrin-1, is critical for the biogenesis of cellugyrincontaining SLMVs. To date there is no information available
that identifies a specific physiologic function(s) associated with
these SLMVs in macrophages or for that matter other cell types.
Kupriyanaova and Kandror (54) did, however, demonstrate that
adipose cells contain cytoplasmic SLMVs that were positive
for both cellugyrin and Glut4. The authors were unable to
demonstrate that the vesicles localized to the plasma membrane
following insulin treatment; nevertheless, it was proposed that
these SLMVs represent early sorting vesicles and are likely a
component of the trans Golgi network (TGN). Chapel et al. (55)
have also proposed that cellugyrin may function as a lysosomal
transporter protein.
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plasma membranes and organelle membranes as these are areas
in which PIP3 pools are generated. In summary, our current
study, in conjunction with our previous findings in lymphocytes,
clearly demonstrate that cellugyrin, and likely cellugyrin
containing SLMVs, play a requisite role in the earliest stages of
internalization and possibly retrograde transport of CdtB from
lipid rafts to intracellular target sites. These observations not
only advance our understanding of upstream events leading
to toxicity, but also identify potential sites for developing
protocols for therapeutic intervention to prevent Cdt mediated
toxicity and inhibit the pathogenesis of disease caused by
Cdt-producing pathogens.

for a group of diseases known as PCV2 Associated Disease.
PCV2 disease exhibits variation in incidence and severity of
disease; investigators proposed this variability is due to missense
mutation in the SYNGR2 gene (cellugyrin) which results in
altered viremia. Experimental silencing of SYNGR expression
was found to significantly reduce PCV2 titers in infected PK15
cells. It was proposed that cellugyrin mutation(s) affect its
incorporation into vesicular membranes and thereby alter vesicle
formation; the altered vesicles fail to transport PCV2 to the
nucleus where the virus replicates.
In conclusion, although little is known about the physiologic
role of cellugyrin and/or cellugyrin containing SLMVs, it is
becoming increasingly clear that they are hijacked by viruses
and the bacterial toxin Cdt. In the case of the latter, CdtB
internalization and transport to intracellular target sites is
dependent upon cellugyrin expression, and likely cellugyrin
(and possibly Derlin-2 as well) containing SLMVs (Figure 6).
It should be noted that there are currently two paradigms
that account for the molecular mechanism by which CdtB
induces toxicity in target cells [reviewed in (1, 22)]. First, CdtB
has been shown to exhibit low level DNase activity. Several
investigators have proposed that this enzymatic activity induces
DNA strand breaks leading to toxicity in proliferating cells:
cell cycle arrest and apoptosis. There is little direct evidence
of DNA damage in Cdt treated mammalian cells; however,
investigators have observed that some types of Cdt treated cells
exhibit activation of the DNA damage response (DDR) (58–61);
this responses utilizes phosphorylation of H2AX as a surrogate
for DNA damage. We have proposed an alternative paradigm
which is based upon our observation that CdtB, derived from
A. actinomycetemcomitans aggregatibacter Cdt, is a potent PIP3
phosphatase; Cdt treated cells exhibit depletion of PIP3 and
downstream PI-3K blockade: decreased phosphorylation of Akt
(inactivation) and GSK3β (activation). Furthermore, we have
demonstrated that CdtB toxicity, which we have observed in both
proliferating cells and non-proliferating cells, is dependent upon
its PIP3 phosphatase activity and not DNase activity (24, 62–65).
It is likely that the operative molecular mode of action relates
to the amount of toxin employed, the bacterial source of Cdt
and the host target cell. Regardless of which mode of action may
be operative, it is clear that they both require internalization
and retrograde transport of CdtB. Clearly, the final intracellular
target site will be closely linked to CdtB’s molecular mode of
action. Toxicity due to PIP3 depletion would require that CdtB
accumulates in close proximity to the intracellular leaflet of
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